IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q4 2020 Results - Earnings Call Transcript

ImmunoGen, Inc. (IMGN) Q4 2020 Earnings Conference Call February 12, 2021 08:00 ET Company Participants Courtney O’Konek - Senior Director, Corporate Communications and Investor Relations Mark Enyedy - President and Chief Executive Officer Anna Berkenblit - Chief Medical Officer Susan Altschuller - Chief Financial Officer Conference Call Participants John Newman - Canaccord Yige Guo - Guggenheim Securities Boris Peaker - Cowen Andy Hsieh - William Blair Kennen MacKay - RBC Capital Markets Luke Brennan - JPMorgan Biren Amin - Jefferies Jonathan Chang - SVB Leerink Swayampakula Ramakanth - H.C. Wainwright Presentation Operator Good morning and welcome to ImmunoGen’s Fourth Quarter and Full Year 2020 Financial and Operating Results Conference call. Today’s conference is being recorded. At this time, I would like to turn the call over to Courtney O’Konek, Senior Director of Corporate Communications and Investor Relations. Please go ahead. Courtney O’Konek Good morning and thank you for joining today’s

For further details see:

ImmunoGen, Inc. (IMGN) CEO Mark Enyedy on Q4 2020 Results - Earnings Call Transcript